ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Biobased chemicals firms Amyris and Cobalt Technologies have raised additional funds from investors. Publicly traded Amyris will receive $28 million in cash from current stockholder Temasek and new investor Wolverine Asset Management in exchange for promissory notes. Amyris makes farnesene from sugar at its facility in Brotas, Brazil. The firm says the funding will help it achieve positive cash flow from operations in 2014. Privately held Cobalt, meanwhile, has raised $4.1 million from its backers, including Life Sciences Partners and VantagePoint Capital Partners. The company is working with two unidentified Asian chemical firms to scale up processes for converting biomass to butadiene and 1-butanol.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter